MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 74 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,902,660 | +6.5% | 7,676,481 | +9.0% | 0.26% | +19.9% |
| Q2 2023 | $9,295,956 | +110.6% | 7,042,391 | +12.8% | 0.22% | +110.5% |
| Q1 2023 | $4,414,518 | -5.7% | 6,244,897 | 0.0% | 0.10% | -7.1% |
| Q4 2022 | $4,683,673 | -12.9% | 6,244,897 | 0.0% | 0.11% | -18.7% |
| Q3 2022 | $5,377,000 | -22.9% | 6,244,897 | +0.2% | 0.14% | -31.5% |
| Q2 2022 | $6,978,000 | +2.6% | 6,230,275 | +2.6% | 0.20% | +18.7% |
| Q1 2022 | $6,804,000 | -23.9% | 6,074,943 | +8.8% | 0.17% | -17.0% |
| Q4 2021 | $8,937,000 | -23.6% | 5,585,621 | +15.6% | 0.21% | -16.3% |
| Q3 2021 | $11,696,000 | -18.8% | 4,832,978 | +6.4% | 0.25% | -13.7% |
| Q2 2021 | $14,401,000 | -4.9% | 4,542,769 | +1.1% | 0.28% | -13.6% |
| Q1 2021 | $15,148,000 | – | 4,494,869 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,854,278 | $6,638,000 | 3.61% |
| Asymmetry Capital Management, L.P. | 739,812 | $2,649,000 | 1.21% |
| Affinity Asset Advisors, LLC | 625,000 | $2,238,000 | 1.19% |
| Tri Locum Partners LP | 728,710 | $2,609,000 | 0.95% |
| Boxer Capital, LLC | 6,226,673 | $22,291,000 | 0.72% |
| DAFNA Capital Management LLC | 668,148 | $2,392,000 | 0.71% |
| Vivo Capital, LLC | 4,220,938 | $15,111,000 | 0.67% |
| Delphi Management Partners VIII, L.L.C. | 256,734 | $919,000 | 0.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 280,000 | $1,002,000 | 0.58% |
| Rubric Capital Management LP | 1,853,417 | $6,635,000 | 0.49% |